[go: up one dir, main page]

WO2000003702A8 - Preparation pharmaceutique et procede correspondant - Google Patents

Preparation pharmaceutique et procede correspondant

Info

Publication number
WO2000003702A8
WO2000003702A8 PCT/SE1999/001280 SE9901280W WO0003702A8 WO 2000003702 A8 WO2000003702 A8 WO 2000003702A8 SE 9901280 W SE9901280 W SE 9901280W WO 0003702 A8 WO0003702 A8 WO 0003702A8
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical preparation
mast cells
analogue
precursor
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/SE1999/001280
Other languages
English (en)
Other versions
WO2000003702A1 (fr
Inventor
Lennart Enerbaeck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
A+ Science AB
Original Assignee
A+ Science Invest AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A+ Science Invest AB filed Critical A+ Science Invest AB
Priority to CA002337049A priority Critical patent/CA2337049A1/fr
Priority to BR9912096-8A priority patent/BR9912096A/pt
Priority to AU55400/99A priority patent/AU5540099A/en
Priority to EP99941927A priority patent/EP1096928A1/fr
Priority to MXPA01000390A priority patent/MXPA01000390A/es
Priority to JP2000559837A priority patent/JP2002520354A/ja
Publication of WO2000003702A1 publication Critical patent/WO2000003702A1/fr
Publication of WO2000003702A8 publication Critical patent/WO2000003702A8/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention concerne une préparation pharmaceutique comprenant au moins une amine, l'un de ses analogues, l'un de ses précurseurs, ou l'un de ses sels pharmaceutiquement acceptable et capable d'être capté par les basophiles et restitué par eux dès la liaison d'un allergène sur un récepteur situé sur les basophiles. Cette préparation pharmaceutique est destinée au traitement et/ou à la prévention de l'allergie. L'invention concerne également le traitement et/ou la prévention de l'allergie par administration à un patient d'une quantité suffisante d'au moins une amine, l'une de ses analogues, l'un de ses précurseurs ou de l'un de ses sels pharmaceutiquement acceptable et pouvant être capté et gardé par les basophiles du patient, puis libérés par les basophiles sous l'effet de la liaison d'un allergène sur un récepteur situé sur les basophiles. Cette substance ne doit être ni une histamine, ni une substance à effets histaminergiques. Cette substance est de préférence une monoamine biogène, l'un des ses analogues ou précurseurs, ou l'un de ses sels pharmaceutiquement acceptables, avec une préférence marquée pour le 5-HTP ou l'un de ses dérivés.
PCT/SE1999/001280 1998-07-16 1999-07-16 Preparation pharmaceutique et procede correspondant Ceased WO2000003702A1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
CA002337049A CA2337049A1 (fr) 1998-07-16 1999-07-16 Preparation pharmaceutique et procede correspondant
BR9912096-8A BR9912096A (pt) 1998-07-16 1999-07-16 Preparação farmacêutica, uso de pelo menos uma amina ou um análogo, um precursor ou um sal farmaceuticamente aceitável da mesma e processo para o tratamento e/ou para a prevenção de alergia
AU55400/99A AU5540099A (en) 1998-07-16 1999-07-16 New pharmaceutical preparation and method
EP99941927A EP1096928A1 (fr) 1998-07-16 1999-07-16 Preparation pharmaceutique et procede correspondant
MXPA01000390A MXPA01000390A (es) 1998-07-16 1999-07-16 Nueva preparacion farmaceutica y metodo.
JP2000559837A JP2002520354A (ja) 1998-07-16 1999-07-16 新規な医薬製剤および方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9802555-4 1998-07-16
SE9802555A SE9802555D0 (sv) 1998-07-16 1998-07-16 New pharmaceutical preparation and method

Publications (2)

Publication Number Publication Date
WO2000003702A1 WO2000003702A1 (fr) 2000-01-27
WO2000003702A8 true WO2000003702A8 (fr) 2000-04-27

Family

ID=20412098

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/SE1999/001280 Ceased WO2000003702A1 (fr) 1998-07-16 1999-07-16 Preparation pharmaceutique et procede correspondant

Country Status (8)

Country Link
EP (1) EP1096928A1 (fr)
JP (1) JP2002520354A (fr)
AU (1) AU5540099A (fr)
BR (1) BR9912096A (fr)
CA (1) CA2337049A1 (fr)
MX (1) MXPA01000390A (fr)
SE (1) SE9802555D0 (fr)
WO (1) WO2000003702A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6773560B2 (en) 1998-07-10 2004-08-10 Semitool, Inc. Dry contact assemblies and plating machines with dry contact assemblies for plating microelectronic workpieces

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2531713A2 (fr) * 1981-09-16 1984-02-17 Panmedica Sa Nouvelles compositions a base de 5-hydroxytryptophane, leur procede de preparation et medicaments les contenant
JPS58177953A (ja) * 1982-04-13 1983-10-18 Eisai Co Ltd ポリプレニルカルボン酸アミドおよびその製造方法
US5126339A (en) * 1983-11-30 1992-06-30 Janssen Pharmaceutica N.V. Anti-allergic bicyclic heterocyclyl-containing N-(bicyclic heterocyclyl)-4-piperidinamines
DE4025726A1 (de) * 1990-08-14 1992-02-20 Boehringer Mannheim Gmbh Bestimmung von biogenen aminen
GB9210632D0 (en) * 1992-05-19 1992-07-01 Fisons Plc Compounds
CA2145410A1 (fr) * 1992-09-24 1994-03-31 Nancy M. Gray Compositions pour le traitement des troubles allergiques contenant de la (-) cetirizine
US5502080A (en) * 1994-11-01 1996-03-26 Hitzig; Pietr Combined use of dopamine and serotonin agonists in the treatment of allergic disorders

Also Published As

Publication number Publication date
CA2337049A1 (fr) 2000-01-27
EP1096928A1 (fr) 2001-05-09
WO2000003702A1 (fr) 2000-01-27
AU5540099A (en) 2000-02-07
JP2002520354A (ja) 2002-07-09
BR9912096A (pt) 2001-05-02
MXPA01000390A (es) 2002-07-02
SE9802555D0 (sv) 1998-07-16

Similar Documents

Publication Publication Date Title
WO2001005763A3 (fr) Composes possedant une activite sur les recepteurs muscariniques
WO2004071529A3 (fr) Utilisations d'anticorps contre le recepteur de facteur de croissance insulinoide i
CA2326804A1 (fr) Composes presentant une activite sur les recepteurs muscariniques
BR9808888A (pt) Formas de dosagem e método de melhorar disfunção erétil masculina
WO2000013662A8 (fr) Systeme d'administration de la nicotine par chewing-gum medicamenteux
AU6675198A (en) Transdermal drug delivery system for the administration of tamsulosin, and related compositions and methods of use
IL144730A (en) Use of statin drug in the preparation of a medicament and as a medicament for the treatment of diabetic neuropathy
AU3136897A (en) Compositions, methods and devices for the transdermal delivery of drugs
NO996310L (no) Sammensetninger og fremgangsmÕter for Õ redusere respirasjonsdepresjon og ledsagende bivirkninger av mu-opioide forbindelser
CA2360248A1 (fr) Combinaisons de formoterol et de sel de tiotropium
BRPI0309544B8 (pt) preparação farmacêutica oral estável ao armazenamento compreendendo oxicodona e naloxona
EE05506B1 (et) Ravimi manustamise vahend eriti progestiinide ja”strogeenide manustamiseks
WO2001043749A3 (fr) Implant pharmacologique contenant des composants a liberation immediate et a liberation prolongee et procede d'administration
IL160983A (en) Use of pyy for preparation of a medicament for modification of feeding behavior
EP1738751A3 (fr) système de libération espacée de médicaments
CA2294921A1 (fr) Levobupivacine et son utilisation
WO2007009806A3 (fr) Formulations posologiques solides de medicaments narcotiques presentant une adsorption buccale amelioree
WO2000078294A3 (fr) Forme galenique orale servant a administrer une combinaison fixe de tramadol et de diclofenac
NO992944L (no) Virkestoffbµrer for avgivelse av apomorfin i munnhulen
NZ514129A (en) Tolperison-containing, pharmaceutical preparation for oral administration
WO1999044608A8 (fr) Nouvelle utilisation
WO2003028715A3 (fr) Nouvelle methode for d'inhibition de l'angiogenese
WO2000010533A3 (fr) Traitement d'infections intracellulaires et compositions a cet effet
WO2002056745A3 (fr) Methode de traitement de la maladie de parkinson
WO2005010022A3 (fr) Polypeptide agoniste de recepteur destine a la toxine zot et a la zonuline

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CU CZ CZ DE DE DK DK EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: C1

Designated state(s): AE AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CU CZ CZ DE DE DK DK EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WR Later publication of a revised version of an international search report
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 55400/99

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 1999941927

Country of ref document: EP

ENP Entry into the national phase in:

Ref document number: 2337049

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: PA/a/2001/000390

Country of ref document: MX

ENP Entry into the national phase in:

Ref country code: JP

Ref document number: 2000 559837

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 509759

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 09743724

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1999941927

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1999941927

Country of ref document: EP